428 related articles for article (PubMed ID: 26739610)
21. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
22. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.
Nieto MC; Tellería O; Cisterna R
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):34-40. PubMed ID: 25439581
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis.
Kale-Pradhan PB; Morgan G; Wilhelm SM; Johnson LB
Pharmacotherapy; 2010 Dec; 30(12):1207-13. PubMed ID: 21114387
[TBL] [Abstract][Full Text] [Related]
24. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives.
Neoh CF; Slavin M; Chen SC; Stewart K; Kong DC
Int J Antimicrob Agents; 2014 Mar; 43(3):207-14. PubMed ID: 24670423
[TBL] [Abstract][Full Text] [Related]
25. Invasive candidiasis in intensive care units in China: a multicentre prospective observational study.
Guo F; Yang Y; Kang Y; Zang B; Cui W; Qin B; Qin Y; Fang Q; Qin T; Jiang D; Li W; Gu Q; Zhao H; Liu D; Guan X; Li J; Ma X; Yu K; Chan D; Yan J; Tang Y; Liu W; Li R; Qiu H;
J Antimicrob Chemother; 2013 Jul; 68(7):1660-8. PubMed ID: 23543609
[TBL] [Abstract][Full Text] [Related]
26. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.
Bassetti M; Righi E; Montravers P; Cornely OA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i14-i25. PubMed ID: 29304208
[TBL] [Abstract][Full Text] [Related]
27. Invasive Candida infections in solid organ transplant recipient children.
Sensoy G; Belet N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):317-24. PubMed ID: 21417871
[TBL] [Abstract][Full Text] [Related]
28. Invasive candidiasis: current clinical challenges and unmet needs in adult populations.
Soriano A; Honore PM; Puerta-Alcalde P; Garcia-Vidal C; Pagotto A; Gonçalves-Bradley DC; Verweij PE
J Antimicrob Chemother; 2023 Jul; 78(7):1569-1585. PubMed ID: 37220664
[TBL] [Abstract][Full Text] [Related]
29. [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis].
Figueras C; Díaz de Heredia C; García JJ; Navarro M; Ruiz-Contreras J; Rossich R; Rumbao J; Frick MA; Roselló EM;
An Pediatr (Barc); 2011 May; 74(5):337.e1-337.e17. PubMed ID: 21396895
[TBL] [Abstract][Full Text] [Related]
30. Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F; Lockhart SR; Berkow EL; Calandra T
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i4-i13. PubMed ID: 29304207
[TBL] [Abstract][Full Text] [Related]
31. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.
Steinbach WJ; Roilides E; Berman D; Hoffman JA; Groll AH; Bin-Hussain I; Palazzi DL; Castagnola E; Halasa N; Velegraki A; Dvorak CC; Charkabarti A; Sung L; Danziger-Isakov L; Lachenauer C; Arrieta A; Knapp K; Abzug MJ; Ziebold C; Lehrnbecher T; Klingspor L; Warris A; Leckerman K; Martling T; Walsh TJ; Benjamin DK; Zaoutis TE;
Pediatr Infect Dis J; 2012 Dec; 31(12):1252-7. PubMed ID: 22982980
[TBL] [Abstract][Full Text] [Related]
32. Candida urinary tract infections--treatment.
Fisher JF; Sobel JD; Kauffman CA; Newman CA
Clin Infect Dis; 2011 May; 52 Suppl 6():S457-66. PubMed ID: 21498839
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of anidulafungin during albumin dialysis.
Aguilar G; Azanza JR; Sádaba B; Badenes R; Ferrando C; Delgado C; Hernández J; Parra MA; Puig J; Carbonell JA; Navarro D; Belda FJ
Crit Care; 2014 Mar; 18(2):422. PubMed ID: 25028805
[No Abstract] [Full Text] [Related]
34. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Martin-Loeches I; Antonelli M; Cuenca-Estrella M; Dimopoulos G; Einav S; De Waele JJ; Garnacho-Montero J; Kanj SS; Machado FR; Montravers P; Sakr Y; Sanguinetti M; Timsit JF; Bassetti M
Intensive Care Med; 2019 Jun; 45(6):789-805. PubMed ID: 30911804
[TBL] [Abstract][Full Text] [Related]
35. Invasive candidiasis: future directions in non-culture based diagnosis.
Posch W; Heimdörfer D; Wilflingseder D; Lass-Flörl C
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):829-838. PubMed ID: 28829207
[TBL] [Abstract][Full Text] [Related]
36. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
37. [Management of invasive candidiasis in non-neutropenic patient].
Cardozo C; Mensa J
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():34-7. PubMed ID: 26365732
[TBL] [Abstract][Full Text] [Related]
38. EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.
Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
Rev Iberoam Micol; 2016; 33(4):196-205. PubMed ID: 27422492
[TBL] [Abstract][Full Text] [Related]
39. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
40. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis.
Pfaller MA; Wolk DM; Lowery TJ
Future Microbiol; 2016; 11(1):103-17. PubMed ID: 26371384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
